Drug intelligence / Profile preview

Triaminic Softchews

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

Triaminic Softchews is a brand of over-the-counter (OTC) combination medications specifically designed for children, originally developed by Novartis. The product line features several formulations tailored to specific symptom clusters, including 'Allergy Sinus', 'Cold and Allergy', 'Chest Congestion', and 'Cough and Runny Nose'. These medications are delivered as chewable tablets ('softchews') to facilitate administration in pediatric populations. The active ingredients vary by formulation but generally include small molecules such as acetaminophen (analgesic/antipyretic), pseudoephedrine (nasal decongestant), chlorpheniramine (antihistamine), and guaifenesin (expectorant). These components work by targeting adrenergic receptors to constrict blood vessels in the nasal passages, blocking H1 receptors to reduce allergic responses, and inhibiting prostaglandin synthesis to alleviate pain and fever. Triaminic products are widely used to manage symptoms of the common cold, influenza, and seasonal allergies.

Brand names
Triaminic SoftchewsTriaminic Softchews Allergy SinusTriaminic Softchews Cold and AllergyTriaminic Softchews Chest CongestionTriaminic Softchews Cough and Runny Nose
02

Targets

ADRB2 (β2)HRH1 (Histamine H1 Receptor)ADRA2A (α2A)ADRA1A (α1A)ADRB1 (β1)DRD1 (Dopamine D1 Receptor)

Beyond the preview

Go deeper on Triaminic Softchews.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triaminic Softchews.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call